Anti-IgE
This ELISA measures IgG antibodies specific for IgE. These autoantibodies have been implicated as a causative agent in autoimmune chronic urticaria. In addition, these autoantibodies have also been implicated as significant in atopic dermatitis and hyper IgE syndrome.
ProcedureIgG antibodies specific for IgE are detected with a solid phase indirect non-competitive ELISA. Human IgE is coated onto polystyrene micro-wells (solid-phase antigen). IgG antibodies in serum that bind to the IgE are detected with a labeled anti-human IgG antibody. This test has not been cleared or approved for diagnostic use by the U.S. Food and Drug Administration.
5-7 business days from receipt of specimen
| Specimen Type | Test Code | CPT Code | NY Approved | Volume | Assay Range | Special Instructions |
|---|---|---|---|---|---|---|
| serum | 2105 | 83516 | Yes | 1 mL (min. 100 uL) |
Resulted as Normal or Elevated. A result of normal indicates that the level of IgG anti-IgE antibodies is similar to that seen in a population of healthy individuals. A result of elevated indicates an increased level of IgG anti-IgE antibodies compared to healthy individuals. |
|
Qualitative test resulted as Normal or Elevated. A result of normal indicates that the level of IgG anti-IgE antibodies is similar to that seen in a population of healthy individuals. A result of elevated indicates an increased level of IgG anti-IgE antibodies compared to healthy individuals.
Specimens are approved for testing in New York only when indicated in the Specimen Information field above.
The CPT codes provided are based on Viracor Eurofins' interpretation of the American Medical Association's Current Procedural Terminology (CPT) codes and are provided for general informational purposes only. CPT coding is the sole responsibility of the billing party. Questions regarding coding should be addressed to your local Medicare carrier. Viracor Eurofins assumes no responsibility for billing errors due to reliance on the CPT codes illustrated in this material.